BRUKINZA Trademark

Trademark Overview

On Thursday, March 21, 2019, a trademark application was filed for BRUKINZA with the United States Patent and Trademark Office. The USPTO has given the BRUKINZA trademark a serial number of 88349805. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by BeiGene, Ltd.. The BRUKINZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
brukinza

General Information

Serial Number88349805
Word MarkBRUKINZA
Filing DateThursday, March 21, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1108
KY

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 17, 2022SOU EXTENSION 5 GRANTED
Thursday, February 3, 2022SOU EXTENSION 5 FILED
Thursday, February 3, 2022TEAS EXTENSION RECEIVED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 1, 2021SOU EXTENSION 4 GRANTED
Wednesday, September 1, 2021SOU EXTENSION 4 FILED
Wednesday, September 1, 2021TEAS EXTENSION RECEIVED
Friday, February 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, January 28, 2021SOU EXTENSION 3 GRANTED
Thursday, January 28, 2021SOU EXTENSION 3 FILED
Thursday, January 28, 2021TEAS EXTENSION RECEIVED
Thursday, August 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020SOU EXTENSION 2 GRANTED
Tuesday, August 18, 2020SOU EXTENSION 2 FILED
Tuesday, August 18, 2020TEAS EXTENSION RECEIVED
Monday, May 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2020SOU EXTENSION 1 GRANTED
Monday, March 2, 2020SOU EXTENSION 1 FILED
Monday, March 2, 2020TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2019ASSIGNED TO EXAMINER
Monday, April 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 25, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

brukinza diseases infectious inflammatory autoimmune treatment cancer pharmaceuticals